Home - Products - Others - Other Targets - Eugenol 4-O-beta-D-(6-O-galloyl) glucopyranoside

Eugenol 4-O-beta-D-(6-O-galloyl) glucopyranoside

CAS No. 152041-15-1

Eugenol 4-O-beta-D-(6-O-galloyl) glucopyranoside( ——— )

Catalog No. M39259 CAS No. 152041-15-1

Eugenol 4-O-beta-D-(6'-O-galloyl) glucopyranoside

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 611 In Stock
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Eugenol 4-O-beta-D-(6-O-galloyl) glucopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Eugenol 4-O-beta-D-(6'-O-galloyl) glucopyranoside
  • Description
    Eugenol 4-O-beta-D-(6'-O-galloyl) glucopyranoside
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    152041-15-1
  • Formula Weight
    478.5
  • Molecular Formula
    C23H26O11
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • (3Z)-1-methyl-3-[2-(...

    (3Z)-1-methyl-3-[2-(4-methylphenyl)-2-oxo-ethylidene]piperazin-2-one is a chemical agent.

  • Schnurri-3 inhibitor...

    Schnurri-3 inhibitor-1, a potent inhibitor of schnurri-3, is an essential regulator of bone formation in adults that can be used in osteoporosis research. Schnurri-3 inhibitor-1 can inhibit Shn3 with EF1alpha promoter in osteoblast cell line Shn3FFL (AC50 = 2.09 μM) .

  • Compound K

    HIV-IN-11 is part of the hydroxylaminoglutaramide (HAPA) transition state isomeric series of HIV protease inhibitors and is a potent and selective inhibitor of HIV-1 protease. HIV-IN-11 competitively inhibits HIV-1 PR (Ki: 0.049 nM) and potently inhibits replication of HIV(IIIb)-infected MT4 lymphocytes at concentrations of 25.0-50.0 nM. HIV-IN-11 displays a longer half-life than indinavir sulfate in animal models and serves as a promising second-generation HIV protease inhibitor.